4BXN | pdb_00004bxn

Eg5(WT) complex


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.79 Å
  • R-Value Free: 
    0.274 (Depositor), 0.288 (DCC) 
  • R-Value Work: 
    0.230 (Depositor), 0.279 (DCC) 
  • R-Value Observed: 
    0.233 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 4BXN

Ligand Structure Quality Assessment 


This is version 1.6 of the entry. See complete history

Literature

The Mitotic Kinesin Eg5 Overcomes Inhibition to the Phase I/II Clinical Candidate Sb743921 by an Allosteric Resistance Mechanism.

Talapatra, S.K.Anthony, N.G.Mackay, S.P.Kozielski, F.

(2013) J Med Chem 56: 6317

  • DOI: https://doi.org/10.1021/jm4006274
  • Primary Citation Related Structures: 
    4A1Z, 4A28, 4AS7, 4B7B, 4BXN

  • PubMed Abstract: 

    Development of drug resistance during cancer chemotherapy is one of the major causes of chemotherapeutic failure for the majority of clinical agents. The aim of this study was to investigate the underlying molecular mechanism of resistance developed by the mitotic kinesin Eg5 against the potent second-generation ispinesib analogue SB743921 (1), a phase I/II clinical candidate. Biochemical and biophysical data demonstrate that point mutations in the inhibitor-binding pocket decrease the efficacy of 1 by several 1000-fold. Surprisingly, the structures of wild-type and mutant Eg5 in complex with 1 display no apparent structural changes in the binding configuration of the drug candidate. Furthermore, ITC and modeling approaches reveal that resistance to 1 is not through conventional steric effects at the binding site but through reduced flexibility and changes in energy fluctuation pathways through the protein that influence its function. This is a phenomenon we have called "resistance by allostery".


  • Organizational Affiliation
    • The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BS, Scotland, U.K. s.talapatra@ed.ac.uk

Macromolecule Content 

  • Total Structure Weight: 86.76 kDa 
  • Atom Count: 5,521 
  • Modeled Residue Count: 692 
  • Deposited Residue Count: 736 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
KINESIN-LIKE PROTEIN KIF11
A, B
368Homo sapiensMutation(s): 0 
UniProt & NIH Common Fund Data Resources
Find proteins for P52732 (Homo sapiens)
Explore P52732 
Go to UniProtKB:  P52732
PHAROS:  P52732
GTEx:  ENSG00000138160 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP52732
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
6LX

Query on 6LX



Download:Ideal Coordinates CCD File
DA [auth B],
N [auth A]
N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methylpropyl]-4-methylbenzamide
C31 H33 Cl N2 O3
PGXYIBJJCLWJST-MUUNZHRXSA-N
ADP

Query on ADP



Download:Ideal Coordinates CCD File
C [auth A],
S [auth B]
ADENOSINE-5'-DIPHOSPHATE
C10 H15 N5 O10 P2
XTWYTFMLZFPYCI-KQYNXXCUSA-N
CD

Query on CD



Download:Ideal Coordinates CCD File
AA [auth B]
BA [auth B]
CA [auth B]
D [auth A]
E [auth A]
AA [auth B],
BA [auth B],
CA [auth B],
D [auth A],
E [auth A],
EA [auth B],
F [auth A],
G [auth A],
GA [auth B],
H [auth A],
HA [auth B],
I [auth A],
J [auth A],
K [auth A],
L [auth A],
T [auth B],
U [auth B],
V [auth B],
W [auth B],
X [auth B],
Y [auth B],
Z [auth B]
CADMIUM ION
Cd
WLZRMCYVCSSEQC-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
FA [auth B]
IA [auth B]
JA [auth B]
M [auth A]
O [auth A]
FA [auth B],
IA [auth B],
JA [auth B],
M [auth A],
O [auth A],
P [auth A],
Q [auth A],
R [auth A]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
Binding Affinity Annotations 
IDSourceBinding Affinity
6LX BindingDB:  4BXN Ki: 0.5 (nM) from 1 assay(s)
Kd: 10 (nM) from 1 assay(s)
IC50: 0.14 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.79 Å
  • R-Value Free:  0.274 (Depositor), 0.288 (DCC) 
  • R-Value Work:  0.230 (Depositor), 0.279 (DCC) 
  • R-Value Observed: 0.233 (Depositor) 
Space Group: P 32
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 81.426α = 90
b = 81.426β = 90
c = 115.202γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
SCALAdata scaling
CCP4phasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2013-07-31
    Type: Initial release
  • Version 1.1: 2013-09-04
    Changes: Database references
  • Version 1.2: 2014-09-17
    Changes: Atomic model, Derived calculations, Non-polymer description
  • Version 1.3: 2019-11-20
    Changes: Advisory, Derived calculations, Other
  • Version 1.4: 2023-03-08
    Changes: Advisory, Database references, Derived calculations
  • Version 1.5: 2024-02-07
    Changes: Data collection, Refinement description
  • Version 1.6: 2025-10-01
    Changes: Advisory, Derived calculations, Structure summary